Fifth issued patent in the U.S. for QTORIN™ rapamycin with anticipated patent life extending into 2038QTORIN™ rapamycin has the potential to be ...

A urinary tract infection (UTI) is a bacterial infection that affects your bladder, urethra, or kidneys. It occurs when bacteria—most commonly E. coli—enter and invade your bladder. Common ...

EPALINGES, Switzerland and PARIS, April 22, 2025 /PRNewswire/ — Onward Therapeutics SA, a biotechnology company dedicated to advancing innovative cancer immunotherapies, announced that its subsidiary, ...

Learn about Brink Therapeutics as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

SEATTLE, WA / ACCESS Newswire / April 21, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company focused on developing novel immune-oncology ...

We are thrilled to welcome Chris to our team at this exciting time for Design, as we advance our portfolio of GeneTAC ® small molecules toward key clinical milestones,” said Pratik Shah, Ph.D., ...

Wound care patients across the PAM Health network of hospitals and outpatient clinics will now have access to an innovative ...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...

Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and ...

As of Tuesday, April 15, iTeos Therapeutics, Inc.’s ITOS share price has surged by 7.59%, which has investors questioning if ...

Nektar Therapeutics’s NKTR share price has surged by 18.21%, which has investors questioning if this is right time to sell.

Financing of Merida Biosciences was backed by Bain Capital Life Sciences, BVF Partners and Third Rock Ventures, with ...